99mTc-Labeled FAPI SPECT and 18F-FDG PET Imaging for Visualization and Evaluation of Connective Tissue Disease-associated Interstitial Lung Disease
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background The pathogenesis of connective tissue disease-associated interstitial lung disease (CTD-ILD) involves complex interactions between inflammatory cell infiltration and fibroblast activation, which are pivotal in driving the disease progression. The aim of the study was to assess the feasibility of 99m Tc-HFAPI imaging for visualizing the active fibrotic process and 18 F-FDG imaging for visualizing the inflammatory process in CTD-ILD patients. Results A total of 54 CTD-ILD patients were enrolled. Visual analysis revealed that nearly half of the patients exhibited intense tracer uptake on 99m Tc-HFAPI imaging, whereas most patients showed slight or mild tracer uptake on 18 F-FDG imaging. 8 patients showed severe uptake in both scans. 15 patients showed slight or mild 18 F-FDG uptake but severe 99m Tc-HFAPI uptake. No instances of severe 18 F-FDG uptake coupled with low 99m Tc-HFAPI uptake were observed among these 54 patients. When comparing the 99m Tc-HFAPI parameters and pulmonary function testing (PFT) results, 99m Tc-HFAPI uptake showed significantly negative correlation with forced vital capacity (FVC) [whole lung (wl) SUVmean: R=-0.45, p < 0.005; metabolic active volume (MAV): R=-0.41, p < 0.005; total lesion (TL): R=-0.45, p < 0.005) and diffusion capacity for carbon monoxide (DLCO) (wlSUVmean: R=-0.58, p < 0.005; MAV: R=-0.62, p < 0.005; TL: R=-0.65, p < 0.005). Significantly positive correlations were observed between 99m Tc-HFAPI parameters and the disease extent on HRCT (wlSUVmean: R = 0.51, p < 0.005; MAV: R = 0.53, p < 0.005; TL: R = 0.64, p < 0.005). In contrast, 18 F-FDG parameters demonstrated weak or mild correlations with both PFT results and disease extent on HRCT. Conclusion 99m Tc-HFAPI imaging shows promising utility in assessing active fibrosis in CTD-ILD patients. Combining 99m Tc-HFAPI with 18 F-FDG imaging enables concurrent visualization and differentiation of fibrotic and inflammatory processes, potentially informing personalized management strategies.